The Division for Neuropharmacology (NEU) serves members with interests in all aspects of neuropharmacology research from studies in the central nervous system to peripheral autonomic pharmacology. Specific areas include, but are not limited to, neurochemistry, neurotransmission, neurotoxicity of drugs, neural receptor pharmacology, signal transduction in neural tissue, mechanisms of nervous system disorders, treatment of nervous system disorders, the pharmacology of drugs acting on the central nervous system and the peripheral nervous system, alcohol and drug addiction, drugs of abuse, and behavioral neuropharmacology.
- To support our junior investigators via travel awards to Experimental Biology for undergraduate students, graduate students, and post-doctoral fellows, early career investigators awards, and mentoring programs
Posting on social media about the NEU division? Use #ASPETNEU.
January 24, 2020
A groundbreaking project from a group led by Dr. Joshua Gross sheds light on how one specific type of opioid receptor, the kappa opioid receptor (KOR), plays an important role in pain and reward.
November 01, 2019
"To introduce undergraduate students to pharmacology research and to use authentic, mentored research experiences in pharmacology to heighten student interest in careers in research and related health care disciplines." That is the vision of the ASPET SURF program and the same vision that the University of Cincinnati (UC) adopts when conducting its own SURF program each year.
September 23, 2019
ASPET member Wael Mohamed, MD, Ph.D, an assistant professor in the Basic Medical Science Department of the International Islamic University in Pahang, Malaysia recently received an ASEAN-India collaborative grant.
Last Updated: June 6, 2019